Is SymBio Pharmaceuticals Limited (SYMQY) a Buy, Sell, or Hold?
OTC : SYMQY
SymBio Pharmaceuticals Limited
$0.5579 USD
$0 (0.0%)
- Volume
- 1
- Average Volume
- 289
- Market Capitalization
- $26.38M
- P/E Ratio
- -0.65
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.19
- Year Low
- $0.56
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.11
Company Overview
OTC
Fuminori Yoshida
Medical - Pharmaceuticals
Healthcare
SYMQY
91
JP
USD
Liquidity Metrics
4.43
1.11
1.04
0.73
0.00
Sales & Valuation
$1.37B
2.98
19.93
0.00
0.00
Profitability
-$99.73
-$5.01B
-458.55%
-456.22%
-424.34%
-198.72%
P/E Metrics
-0.65
0.05
0.05
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-23.89
2/9
$298.55M
$2.96B
$2.73B
-$5.77B
Key Metrics (TTM)
$2.93B
2.30
-0.52
1.11
-424.34%
-444.00%
-126.84%
0.00%
241 days
Company Executives
| Name | Title |
|---|---|
| Minori Rosales | Corporate Officer, CMO Oncology & Neurology and Head of Japan Development Division |
| Fuminori Yoshida | Chief Executive Officer, President & Representative Director |
| Edwin Rock | Corporate Officer, Corporate VP and Head of Global R&D Division |
| Tomonori Seta | Corporate Officer |
| Yoshiharu Torikai | Corporate Officer |
| Hiroyuki Horita | Corporate Officer |
| Masahiko Okuno | Corporate Officer |
Poll Results
No votes yet today — be the first to share your view!
About SymBio Pharmaceuticals Limited (OTC:SYMQY) Stock
SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded by Fuminori Yoshida on March 25, 2005 and is headquartered in Tokyo, Japan. ...
Frequently Asked Questions
-
What is the current SymBio Pharmaceuticals Limited (SYMQY) stock price?
-
SymBio Pharmaceuticals Limited(OTC:SYMQY) stock price is $0.5579 in the last trading session. During the trading session, SYMQY stock reached the peak price of $1.19 while $0.5579 was the lowest point it dropped to. The percentage change in SYMQY stock occurred in the recent session was 0.0% while the dollar amount for the price change in SYMQY stock was $0.
-
SYMQY's industry and sector of operation?
-
The OTC listed SYMQY is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.
-
Who are the executives of SYMQY?
-
Minori Rosales | Corporate Officer, CMO Oncology & Neurology and Head of Japan Development Division
Fuminori Yoshida | Chief Executive Officer, President & Representative Director
Edwin Rock | Corporate Officer, Corporate VP and Head of Global R&D Division
Tomonori Seta | Corporate Officer
Yoshiharu Torikai | Corporate Officer -
How many employees does SYMQY have?
-
Number of SYMQY employees currently stands at 91. SYMQY operates from Toranomon Towers Office, Tokyo, TY 105-0001, JP.
-
Link for SYMQY official website?
-
Official Website of SYMQY is: https://www.symbiopharma.com
-
How do I contact SYMQY?
-
SYMQY could be contacted at phone #81 3 5472 1125 and can also be accessed through its website. SYMQY operates from Toranomon Towers Office, Tokyo, TY 105-0001, JP.
-
How many shares of SYMQY are traded daily?
-
The average number of SYMQY shares traded daily for last 3 months was 289.
-
What is the market cap of SYMQY currently?
-
The market value of SYMQY currently stands at $26.38M with its latest stock price at $0.5579